FromAstraZeneca ([email protected])
Subject (47)AstraZeneca licenses lipid lowering Lp(a) asset
Preheader (114)AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy
Arial
Text Analysis
Body Words225
Subject Words6
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px790 px
X-Spam Score-0.2
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEvening
